Despite antioxidant defenses, such as superoxide dismutases and glutathione peroxidases, oxidative stress represents a constant danger to cell and organismal viability. Reactive oxygen and nitrogen species can cause protein, lipid, sugar, DNA, and RNA modification. Oxidative modifications to proteins are common, and a major cellular defense strategy is to rapidly degrade mildly oxidized proteins before they can aggregate and cross-link to form insoluble cell inclusion bodies (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) .
Insufficient proteolytic capacity or increased oxidant generation, or both, can result in compromised cell function or even cell death (1, 12, (17) (18) (19) (20) (21) (22) (23) (24) . Over a period of many years, we (1) (2) (3) (4) (5) (6) 15) and others (11) (12) (13) (14) 16, 25) have demonstrated that the bulk of oxidatively damaged proteins in the cytoplasm, endoplasmic reticulum, and nucleus are degraded by the Proteasome. More recently, we have also shown that the Immunoproteasome plays a significant role (26, 27) . In mitochondria, oxidized proteins are preferentially degraded by the Lon protease (7) (8) (9) (10) 28) .
In previous studies, we have demonstrated that mammalian cells, as well as bacteria and yeast, can transiently adapt to oxidative stress (19, 26, (29) (30) (31) . This is an adaptive process (sometimes called hormesis) in which cells treated with a mild dose of an oxidant will, for a period of time (≈24-48 h), become more resistant to a higher dose of the same (or related) oxidant that would normally be toxic. Recently, we have demonstrated that this adaptive response includes an increased abundance of 20S Proteasomes, Immunoproteasomes, and PA28αβ (or 11S) Proteasome regulators (26) ; all these proteins were shown to play key roles in the oxidative stress response, and each was required for full adaptation Other groups have also reported induction of various forms of the Proteasome, and Proteasome regulators, by oxidative stress (32) (33) (34) (35) (36) .
The Nrf2 [Nuclear factor (erythroid-derived 2)-like 2] transcription factor is an important component of responses to oxidative stress (37) (38) (39) (40) (41) (42) (43) (44) . Under non-stressful conditions, Nrf2 is maintained at low levels through rapid degradation via Keap1-dependent ubiquitin conjugation (44) (45) (46) , followed by targeted degradation by the 26S Proteasome. As a product of this rapid turnover, newly translated Nrf2 is found predominantly in the cytoplasm. With Keap1 inactivation, as a product of factors such as oxidative stress, Nrf2 levels increase due to diminished proteasomal degradation, and Nrf2 is phosphorylated and translocated to the nucleus in in mechanisms mediated by PKCδ and Akt (47) . Once in the nucleus, Nrf2 binds to a cis-acting enhancer sequence, upstream of numerous antioxidant genes, known as the antioxidant response element (ARE) or electrophile responsive element (EpRE), and promotes the synthesis of several antioxidants, and enzymes responsible for repairing/removing oxidative damage and restoring cell viability (37) .
It has been shown that Nrf2 knock-out in mice results in decreased tolerance to oxidative stress (48, 49) . Additionally, results by Kwak et al (44) showed that the phenolic antioxidant 3H-1,2-dithiole-3-thione (D3T), which induces many cellular antioxidants and phase 2 enzymes, can also enhance mammalian Proteasome expression through the Keap1-Nrf2 signaling pathway. These results led us to hypothesize that the transient stress-adaptation, involving Proteasome and Proteasome regulators, that we described previously (26) , might be primarily under the control of the Nrf2 transcription factor. In the present study we have, therefore, tested whether oxidative stress-induced increases in 20S Proteasome, Immunoproteasome and the Pa28αβ regulator, as well as increased stress-resistance, are actually under the control of Nrf2, and whether Nrf2 is necessary and/or sufficient for their induction and for adaptation to various forms of oxidative stress. Adaptation to Oxidants -MEF cells were grown to 10% confluence (≈250,000 cells per ml) then pre-treated with 100 nM -100 µM H 2 O 2 (catalog # H1009-100ml) from SigmaAldrich (St Louis, MO, USA), 1 nM -1 µM peroxynitrite (catalog # 516620) from Merck (Darmstadt, Germany), 0.2 nM -100 nM menadione (catalog # ME105) from Spectrum Chemicals (Gardena, CA, USA), or 10pM -100 nM paraquat (catalog # PST-740AS) from Ultra Scientific (Kingstown, RI, USA), for 1 h at 37 o C under 5% CO 2 to induce adaptation to oxidative stress. Cells were then washed once with phosphate-buffered saline (PBS), which was finally replaced with fresh complete media.
EXPERIMENTAL PROCEDURES

Materials -
Induction or inhibition of Nrf2 -MEF cells were grown to 5% confluence and treated with varying concentrations of Nrf2 inducers. DL-sulforaphane (catalog # S2441-5mg) or curcumin (catalog # C1386-5G) from Sigma Aldrich (St Louis, MO, USA). Lipoic Acid (catalog #L1089) was purchased from Spectrum Chemicals (Gardena, CA, USA), dissolved in N,N,Dimethylformaldehyde, and combined with complete media at a final concentration of 0.1%; and a comparable concentration of N,N,Dimethylformaldehyde was added to control cells. Curcumin was dissolved in ethanol and combined with complete media at a final concentration of 0.1%, and a comparable concentration of ethanol was added to control cells. In some assays cells were treated with the Nrf2 inhibitor all-Trans-retinoic acid (catalog # R2625-100MG) purchased from Sigma Aldrich (St Louis, MO, USA). Trans-retinoic acid was dissolved in ethanol and combined with complete media at a final concentration of 0.1%; a comparable concentration of ethanol was added to control cells.
Western blot analysis -MEF cells were harvested from 25- (5, 12, 15, 26) , in which % degradation = 100 x (acid-soluble counts − background counts) / total counts.
Cell counting assay -Cells were seeded in 100µl samples at a density of 100,000 cells per ml in 48 well plates. Twenty four hours after seeding, some cells were pre-treated with an oxidant or an Nrf2 inducer. At 48 h after seeding, cells were challenged with a toxic dose of 100 µM -1 mM hydrogen peroxide for 1 h followed by addition of fresh complete media. Cells were harvested 24 h after challenge, using trypsinization. The cell density of 100μl samples of cell suspensions was then obtained using a Cell Counter purchased from Beckman Coulter (Fullerton, CA, USA).
Chromatin Immunoprecipitation (ChIP) Assay -Four million cells were prepared at 10% confluence, the cells were exposed to either 0 or 1μM H₂O₂ for 1h. ChIP analysis was performed using the reagents and methods provided in a Chromatin Immunoprecipitation Assay Kit (catalogue# 17-295) purchased from Millipore (Temecula, CA, USA). Briefly cells were crosslinked with 1% formaldehyde for 10 minutes, washed twice with PBS, dislodged through scraping and re-suspended in 1ml of 1% SDS lysis buffer containing protease inhibitor. Samples were sonicated using 10 bursts of 5 seconds, output of 50 watts (Branson Sonifier 140, Branson Ultrasonic, Danbury, CT), and then centrifuged at 13,000g for 10 minutes. The supernatant was removed and diluted in a 10 fold excess of ChIP dilution buffer. (1% of samples were removed at this point to later form the input samples). Samples were pre-cleared using a 30 minute incubation with 30μl/ml of Salmon Sperm DNA/Protein A Agarose Slurry. Samples were then incubated for 1h with 8μg/ml of Nrf2 antibody (catalog # sc-13032) purchased from Santacruz Biotechnology (Santa Cruz, CA, USA) then 30μl/ml of Salmon Sperm DNA/Protein A Agarose slurry was added and samples were incubated overnight at 4 o C under gentle agitation. After this, the bead slurry was subjected to sequential 10 minute washes with Low Salt Immune Complex, High Salt Immune Complex, LiCl Immune complex and TE buffer. Samples were detached from the bead slurry with two washes of 250μl of 1% SDS 0.1M NaHCO 3 , then reverse cross-linked by incubation with 200μM of NaCl for 4h at 65 o C. 10μM EDTA, 40µM Tris-HCl, and 20μg of Proteinase K was then added to the samples and samples were incubated for 1h at 45°C. DNA was isolated and purified from the samples using phenol-chloroform-isoacyl alcohol. PCR was then performed on samples as described below. 5µl of DNA from each sample was combined with 15µl of the PCR SyBr Green Master Mix (catalog # 4367659) purchased from Applied Biosystems (Warrington, UK), 1.5µL each of 5µM working solutions of forward and reverse PSMB5 primers designed by Kwak et al (44) (catalog # 2110654) and purchased from Invitrogen (Carlsbad, CA, USA), and 7µl of DNAse/RNAse-free ddH 2 O. The forward primer sequence used was CAGACCGGCGCTGGTATTTAGAGG and the reverse primer sequence was TAGCCAGCGCCATGTTTAGCAAGG. PCR was carried out in a 7500 Real Time PCR System device from Applied Biosystems, using an annealing temperature of 61 o C and an extension temperature of 72 o C, for a total of 55 cycles. PCR products were then examined on a 1% agarose gel containing 0.001% ethidium bromide.
Real-time PCR assay of mRNA levels -Total RNA was extracted using TRIzol reagent and treated with DNAfree reagent according to the manufacturer's (Invitrogen, Carlsbad, CA, USA, catalog# 1908) protocol to remove DNA. RNA samples were then reverse-transcribed using the TaqMan random hexamers (catalog# N808 -0234) purchased from Applied Biosystems (Branchburg, NJ, USA) and the mRNA levels were measured by real-time PCR polymerase chain reaction (RT-PCR) using a 7500 real-time PCR system purchased from Applied Biosystems. In brief, 5μl of reverse transcription reaction product was added to a reaction tube containing 12.5μl of SYBR green PCR Master Mix (catalog# 4367659), 5.5μl of sterile water and 1μl of a 5μM working solution of each primer (forward and reverse) for the proteasome subunit β5 subunit or GAPDH mRNA. The total PCR sample reaction was 25μl. The primer sequences used were as follows: 20S proteasome subunit β5: 5′-GCTGGCTAACATGGTGTATCAT-3 and 5′-AAGTCAGCTCATTGTCACTGG-3 as used previously (44) . GAPDH: 5'-GATGCAGGGATGATGTTC-3' and 5'-TGCACCACCAACTGCTTAG-3'.
RESULTS
H 2 O 2 , peroxynitrite, paraquat, and menadione pretreatment all increase proteolytic
capacity. We have previously reported that adaptation to H 2 O 2 includes large increases in proteasomal proteolytic capacity (26) . We now needed to determine if the increase in Proteasome is specific to H 2 O 2 , or if it is a more general response to oxidants. We first pretreated MEF cells with various concentrations of H 2 O 2 , peroxynitrite, or the redox cycling agents paraquat and menadione for 1 h. Then, 24 h later, we harvested and lysed the cells and measured proteolytic capacity by degradation of the fluorogenic peptide, suc-LLVY-AMC which is widely used to estimate the chymotrypsin-like activity of the Proteasome (5,26,51). We saw a 2-fold increase in proteolytic capacity with H 2 O 2 or paraquat pre-treatment, a 2.5-fold increase with peroxynitrite pre-treatment and a 2-3 fold increase with menadione pre-treatment (Fig. 1A-D) . In lysates of untreated cells, the selective Proteasome inhibitor lactacystin caused an 80-90% inhibition of proteolysis. In lysates of oxidant pre-treated cells, lactacystin inhibited degradation by 90-95%, indicating that Proteasome is largely responsible for most of the oxidant-induced adaptive increase in proteolytic capacity (Fig. 1A-D) . This experiment was repeated using another Proteasome-selective inhibitor, MG132 which blocked 50% of activity in untreated cells, and 60% of activity following under oxidative stress adaptation (Fig. 1E-F) .
H 2 O 2 adaptation increases Nrf2 protein levels and Nrf2 nuclear translocation. ARE/EpRE sequences are present in the upstream un-translated region of all 20S Proteasome subunit genes examined. If Nrf2 is involved in our model of adaptation to oxidative stress, we would expect to see an increase in total Nrf2 protein levels as a product of enhanced stability following detachment from the Keap1 complex, as well as translocation of Nrf2 from the cytosol to the nucleus: indicative of Nrf2 functioning as a nuclear transcription factor (39, 40, 45) . For initial experiments we used H 2 O 2 as our adaptive oxidant and found that a mild dose of H 2 O 2 caused a two-fold increase in cellular Nrf2 levels (Fig. 2A) ; this is consistent with previous reports of stress-related induction of Nrf2 (38, 40, 42, 44, 45) . When we blocked Nrf2 synthesis, using Nrf2 siRNA, we lost the increase in Nrf2 protein (Fig. 2B) . We next examined Nrf2 localization using immunocytochemistry, and saw a notably stronger nuclear-localized staining of Nrf2 in H 2 O 2 treated cells compared to a more widespread staining of all cell compartments in untreated cells (Fig. 2C) .
Nrf2 is an important regulator for the H 2 O 2 induced increase in proteolytic capacity. Having determined that Nrf2 levels were increased, and that Nrf2 translocated to the nucleus under the conditions of our cellular H 2 O 2 adaptation model, we next wanted to determine if Nrf2 is actually required for the increased proteolytic capacity reported in Fig 1. To examine this we blocked Nrf2 expression by two distinct methods: siRNA and retinoic acid. First, we explored for an Nrf2 siRNA treatment level and time period that would not diminish basal Nrf2 levels, as Nrf2 is maintained at extremely low levels in unstressed cells, but would block adaptive increases in Nrf2. As shown in both Fig. 2B and the inset to Fig. 3A , we were successful in blocking the oxidative stress-induced increase in Nrf2 levels, without reducing the basal levels of Nrf2. Cells pretreated with Nrf2 siRNA and then exposed to an adaptive dose of H 2 O 2 did not exhibit an H 2 O 2 induced increase in proteolytic capacity, but cells treated with a scrambled siRNA vector showed a normal induction of proteolytic capacity (Fig. 3A) . As a further test of Nrf2 involvement, we repeated the experiment of Fig  3A, using retinoic acid treatment, which has been shown to prevent Nrf2 expression in cells (52) , as a different means of blocking Nrf2. When we pre-treated cells with retinoic acid and then attempted to adapt the cells to H 2 O 2 as in Fig 3A, we saw no significant increase in Nrf2 levels, and no increase in proteolytic capacity (Fig. 3B) .
Nrf2 (Fig. 3C) . The results of Fig 3 provide strong (Fig. 4A-C) . With Nrf2 siRNA pre-treatment, however, the H 2 O 2 induced increase in 20S Proteasome (Fig. 4A) and PA28αβ (Fig. 4B) was lost, indicating that 20S Proteasome and PA28αβ are regulated by Nrf2 during adaptation to stress. In contrast to 20S Proteasome and PA28αβ, Nrf2 siRNA treatment had only a weak effect on the H 2 O 2 induced increase in Immunoproteasome levels (Fig. 4C) . Nevertheless, H 2 O 2 mediated increases in 20S Proteasome, Immunoproteasome, and Pa28αβ were clearly all important for adaptive increases in cell tolerance (survival) of H 2 O 2 challenge treatments (Fig. 5A) . Thus, we must conclude that Immunoproteasome regulation during oxidative stress is either wholly or partially independent of Nrf2, and other factor(s) must be involved. In support of this idea, we find that, although 20S Proteasome subunits contain a few ARE/EpRE sequences in their promoter regions, ARE/EpRE sequences are completely absent in two of the three Immunoproteasome-specific subunits (Fig. 5B ). While such analyses are not conclusive, the results are certainly suggestive. We confirmed that at least some of the EpRE elements upstream of 20S Proteasome subunits are not only present, but H 2 O 2 induces binding of Nrf2 to these sequences. To test this we performed a chromatin immunoprecipiation assay (ChIP) on an EpRE element in the 5'-untranslated region (5'-UTR) of the Proteasome β5 subunit gene, which has previously been shown to have functional EpRE elements (44) . This EpRE element showed a strong increase in Nrf2 binding under H 2 O 2 exposure (Fig. 5C ), thus demonstrating that 20S Proteasome induction under our H 2 O 2 adaptation conditions is mediated by the Nrf2 signal transduction pathway. Using RT-PCR, we were also able to demonstrate a corresponding, hydrogen peroxide-induced, two-fold, increase in cellular mRNA levels of the 20S proteasome β5 subunit during the same time period (Fig. 5D) .
Pre-treatment with Nrf2 'inducers' causes increased tolerance to oxidative stress.
We have developed a transient oxidative stressadaptive model in which pre-treatment of cells with a low concentration of H 2 O 2 causes changes in gene expression that permit survival of a much higher, normally toxic, challenge dose of H 2 O 2 delivered 24 h later (26, 30) . Without pre-treatment with a mild dose of H 2 O 2 , the challenge dose causes protein oxidation, growth arrest, diminished DNA and protein synthesis, and some degree of apoptosis; all these measures of toxicity are avoided or minimized if cells are adapted by pre-treatment with a mild dose of H 2 O 2 before being exposed to the challenge dose (26, (29) (30) (31) 55) . We now wanted to test if adaptive resistance to H 2 O 2 toxicity could be achieved by pre-treatment with a wide range of Nrf2 inducers (both oxidative and nonoxidative). In other words, we wanted to test whether adaptive increases in oxidative stress resistance, via increased proteasomal capacity, is a general feature of the Nrf2 signal transduction pathway. As shown in Fig 6A, 1 .0 mM H 2 O 2 challenge caused a 65% decrease in cell counts in non-adapted, naïve, cells; this was mostly due to prolonged growth arrest, as previously shown (26, (29) (30) (31) 55) . In contrast, cells that had been pre-treated with (low concentrations of) a range of oxidants exhibited substantially less toxicity: only a 29% growth arrest with H 2 O 2 pretreatment, 37% with paraquat, 42% with menadione, and 50% with peroxynitrite (Fig.  6A) . We also tested other inducers of Nrf2, including DL-sulforaphane (56-58), curcumin (59) (60) (61) (62) , and lipoic acid (63) (64) (65) . Growth-arrest induced by H 2 O 2 challenge was decreased (from 65%) to 39% with DL-sulforaphane pretreatment, to 31% with curcumin pre-treatment, and to only 35% with lipoic acid pre-treatment (Fig. 6A) . While it is important to note that these agents are not exclusive inducers Nrf2, the fact that all produced protective effects provides additional support for an important role for Nrf2 in oxidative stress adaptation.
Nrf2, 20S Proteasome, PA28αβ and Immunoproteasome all play important roles in the H 2 O 2 induced adaptive increase in oxidative stress tolerance.
The 20S Proteasome, the Immunoproteasome and the PA28αβ regulator all seem to play important roles in adaptation (26) . We now confirmed this conclusion, using siRNA directed against the 20S Proteasome, Immunoproteasome and PA28αβ regulator. With H 2 O 2 challenge there was a 55% decrease in cell growth; this was reduced to only a 30% decrease with H 2 O 2 pre-treatment and adaptation (Fig.  5A) . However, if cells were first pre-treated with siRNA against 20S Proteasome, Immunoproteasome or PA28αβ, the adaptive response was severely blunted and H 2 O 2 challenge induced growth-arrest returned to 50-60% (Fig. 5A) . Having shown that Nrf2 plays a key regulatory role in H 2 O 2 induced increases in 20S Proteasome and PA28αβ (Fig. 4) we were interested in testing if the adaptive role of these proteins in increasing tolerance to H 2 O 2 challenge is also Nrf2 dependent. Using the 'pre-treatment & challenge model' there was a shift from 65% growth arrest to only 35% growth arrest with H 2 O 2 pre-treatment; this returned to 67% growth arrest if cells were pretreated with Nrf2 siRNA (Fig. 6B) , indicating a significant role for Nrf2 in H 2 O 2 induced tolerance to oxidative stress.
Nrf2 and Proteasome are key factors in the adaptive increase in tolerance to oxidative stress produced by Nrf2 'inducers'.
Having observed an adaptive response with the use of multiple Nrf2 'inducers' we wanted to determine if Proteasome and the Pa28αβ regulator are always involved in Nrf2-dependent adaptation. To test this we performed western blots on cells 24 h after pre-treatment with a range of concentrations of various Nrf2 inducers. We observed modest increases (≈40%) in 20S Proteasome with lipoic acid and curcumin treatment, and more than a two-fold increase with DL-sulforaphane (Fig. 7A) . To test the role of both Nrf2 and Proteasome in the adaptive response to Nrf2 'inducers' we used the pretreatment & challenge model of Fig 6, with a background of scrambled siRNA, Nrf2 siRNA or 20S Proteasome siRNA (Fig. 7B) . With H 2 O 2 challenge of non-adapted cells there was a 68% growth-arrest. Lipoic acid pre-treatment reduced growth arrest to ≈50%; however, growth arrest was returned to ≈85% with either Nrf2 or 20S Proteasome siRNA treatment. Similarly, DLsulforaphane treatment reduced growth arrest to ≈40%, which was returned to ≈85% with either Nrf2 or 20S Proteasome siRNA treatment. Curcumin treatment reduced growth arrest to ≈40% which was restored to ≈85% with 20S Proteasome siRNA and to 70% with Nrf2 siRNA (Fig. 7B) .
DISCUSSION
Our studies reveal a mechanistic link between Nrf2, the 20S Proteasome, the PA28 αβ (11S) Proteasome regulator, and transient adaptation to oxidative stress. It now appears clear that the Nrf2 signal transduction pathway plays a major role in both the increased proteasomal capacity to degrade oxidized proteins, and the increased cellular tolerance to oxidative stress that are induced by pretreatment with a mild dose of oxidant.
We find that cellular capacity to degrade oxidized proteins, and intracellular levels of the 20S Proteasome, Immunoproteasome, and the PA28αβ (11S) regulator are all increased two-to three-fold during adaptation to oxidative stress. Similar results were obtained with the oxidants H 2 O 2 and peroxynitrite, and the redox-cycling agents menadione and paraquat. Proteasome inhibitors, and siRNA directed against the 20S Proteasome β1 subunit, the Immunoproteasome β1i (LMP2) subunit, or the PA28α (11S) regulator subunit, all significantly limited the increase in cellular proteolytic capacity and partially prevented the increased resistance to oxidative stress (cell growth). Cellular levels of Nrf2 were significantly increased by adaptation to oxidative stress, and Nrf2 was seen to translocate to the nucleus, and to bind to ARE/EpRE sequence(s) upstream of the Proteasome β5 subunit gene. Blocking the induction of Nrf2, with siRNA or with retinoic acid, significantly limited the adaptive increases in cellular proteolytic capacity, 20S Proteasome and the Pa28αβ regulator. Increases in the Immunoproteasome, however, were only partially blocked by Nrf2 siRNA. Blocking Nrf2 induction also limited the increase in oxidative stress resistance (cell growth). When, instead of using oxidant exposure, we pretreated cells with the Nrf2 inducers lipoic acid, curcumin, or sulforaphane, we observed increased cellular proteolytic capacity, increased 20S Proteasome, and increased cellular resistance to oxidative stress (cell growth); both Nrf2 siRNA and 20S Proteasome β1 subunit siRNA effectively blocked these increases.
These results suggest that oxidants, redox cycling agents, and other Nrf2 'inducers' cause adaptation through the upregulation of Nrf2 and its translocation to the nucleus. This, in turn, induces expression of the 20S Proteasome and the PA28αβ regulator. In contrast, the Imunoproteasome, whose levels were also increased by adaptation to oxidative stress, appears to be only partially regulated by Nrf2, if at all.
The Nrf2 signal transduction pathway is known to respond to stressful conditions (37) (38) (39) (40) (41) (42) (43) (44) (45) (46) 66) . Under non-stress conditions Nrf2 is retained in the cytoplasm through the formation of a complex with several proteins, including Keap1. In this state it is constantly turned over through ubiquitin-dependant 26S Proteasome degradation. This permits a high expression rate, enabling rapid accumulation of Nrf2 when degradation is blocked, while ensuring low Nrf2 steady-state levels under normal conditions. Pretreatment with an oxidant, or other Nrf2 inducer, liberates Nrf2 from the Keap1 complex. This also prevents further Nrf2 degradation resulting in a dramatic rise in Nrf2 cellular levels as well as its translocation to the nucleus. Once there, it can bind to anti-oxidant response elements (ARE's) that have also been called electrophile response elements (EpRE's), in a range of genes.
We find that genes encoding many 20S Proteasome subunits contain at least one if not multiple ARE/EpRE sequences in their upstream, untranslated regions (Fig. 5B) and have shown that at least some of these ARE/EpRE sequences have a strong increase in Nrf2 binding under H 2 O 2 exposure. In contrast, we find only a single subunit of the three Immunoproteasome subunits contains the ARE/EpRE sequence. It is tempting to suggest that this difference in density of ARE/EpRE sequences may explain the differential sensitivity of the 20S Proteasome and the Immunoproteasome to Nrf2 siRNA and retinoic acid, and to propose that Immunoproteasome may be regulated by another mechanism.
Nrf2 is not the only protein that can bind to ARE/EpRE sequences, and it is certainly possible that other signal transduction proteins may bind to proteasomal and Pa28αβ (11S) regulator ARE/EpRE elements, and/or to Immunoproteasome. We are also searching for other potential pathways for Immunoproteasome induction, of which the Interferon Regulatory Factor 1 (67-69) appears to be a good candidate. Finally, there may well be overlapping pathways of signal transduction that act synergistically, or antagonistically, to dynamically adjust Proteasome/Immunoproteasome levels during adaptation to oxidative stress.
In conclusion, we find that increases in 20S Proteasome and Pa28αβ (11S) regulator expression are largely mediated by the Nrf2 signal transduction pathway during adaptation to oxidative stress. These Nrf2-dependent increases in 20S Proteasome and Pa28αβ (11S) are shown to be important for fully effective adaptive increases in cellular stress resistance. In contrast, the Immunoproteasome, which also contributes to oxidative stress adaptation, is shown to be minimally responsive to Nrf2 control.
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Kraft, D. C., Deocaris, C. C., Wadhwa, R., and Rattan, S. Namiki, S., Nakamura, T., Oshima, S., Yamazaki, M., Sekine, Y., Tsuchiya, K., Okamoto, R., Kanai, T., and Watanabe, M. Fig. 1 : Oxidant Pre-treatment Increases Proteolytic Capacity in a Proteasome Dependent Manner. Cells treated with a mild dose of a range of oxidants exhibit increased proteolytic capacity, the majority of which (80-95%) is blocked by the Proteasome selective inhibitor lactacystin. MEF cells were grown to 10% confluence (≈250,000 cells per ml) and treated with A: 0μM -100μM H 2 O 2 , B: 0μM -1μM Peroxynitrite, C: 0 nM -100 nM Paraquat or D: 0 nM -100 nM Menadione. All treatments were for one h in complete media, following which the media was removed and replaced with fresh complete media (see Experimental Procedures). After 24 h, cells were lysed and diluted to a protein concentration of 50μg per ml. Proteolytic capacity was determined by cleavage of the Proteasome chymotrypsin-like substrate suc-LLVY-AMC (see Experimental Procedures). Where used, 5μM Lactacystin was added to samples, 30 minutes prior to incubation with suc-LLVY-AMC. Values are Means ± SE, n = 3. E: MEF cells were prepared as described in A and pre-treated with 100nM peroxynitrite, 1μM H 2 O 2 , 1nM menadione, or 1nM paraquat for one hour in complete media; following this, the media was removed and replaced with fresh complete media. In some samples, 1μM MG132 was added 30 minutes prior to incubation with suc-LLVY-AMC. Cells were incubated, harvested lysed, diluted and analyzed for proteolytic capacity by lysis of the fluorogenic peptide suc-LLVY-AMC, as in panels A-D, and Experimental Procedures. Values are Means ± SE, n = 3. F: Results from E were re-plotted with the decrease in activity resulting from addition of MG132 plotted as a percent of the proteolytic capacity of cells not treated with the inhibitor. (5, 12, 15, 26) . Percent protein degradation was determined by release of acid soluble counts in TCA supernatants, by liquid scintillation as follows: % degradation = (acid soluble counts -background counts) / total counts x 100. Results are Means ± SE, n = 3. Cells were grown to 10% confluence then exposed to 1μM H 2 O 2 for 1 h. ChIP analysis was then performed as described in Experimental Procedures. Non-specific binding was measured through performing a ChIP assay in the absence of the Nrf2 antibody and input was as a internal control by representing 1% of the sample prior immunoprecipitation. D. H 2 O 2 treatment causes increased mRNA expression of the 20S proteasome β5 subunit. Cells were grown to 10% confluence then exposed to 1μM H 2 O 2 for 1 h. After this cells were harvested, the mRNA levels of the 20S proteasome subunit β5 and the loading control GAPDH were then determined through reverse transcriptase PCR followed by qPCR. Values are plotted, in arbitrary units, adjusted by levels of GAPDH. Values are Means ± SE where n = 3 by guest on August 29, 2017 
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